Nasdaq · CIK 0001468492
HSCS HeartSciences Inc.
Insider trading from SEC Form 4. Last filing Jul 9, 2026. Close $3.18 on Oct 9, 2026, +90% from the 52-week low and -39% from the high.
In brief
HeartSciences Inc. (HSCS) has 21 SEC Form 4 filings on file from 6 insiders, the latest filed on Jul 9, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at HSCS. The newest: Mark T Hilz (COO, Secretary and Director) sold $16k of stock on Jul 29, 2025, filed Jul 30, 2025, scored 10 (weak), under a 10b5-1 plan.
1 Form 144 notice of planned sales is on file, the latest filed Jul 29, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at HeartSciences Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Mark T Hilz COO, Secretary and Director sell | $16k 4,416 shares | -48% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 29, 2025 | HILZ MARK T Officer, Director | 4,416 0.23% of outstanding | $16k | Jul 29, 2025 | none |
Transactions
Every row filed, 23 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Danielle Watson See Remarks | AGrant or award Restricted Stock Unitsderivative | +25,000 | $0.00 | $0 | 25,000 | Jul 9, 2026 |
| Jun 22, 2026 | Andrew Simpson See Remarks | AGrant or award Common Stock, $0.001 par value | +425,000 | - | - | 499,382 | Jun 24, 2026 |
| Jan 12, 2026 | Bruce Bent director | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Jan 12, 2026 |
| Jan 12, 2026 | David R. Wells director | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Jan 12, 2026 |
| Dec 22, 2025 | Mark T Hilz See Remarks | AGrant or award Restricted Stock Unitsderivative | +45,000 | $0.00 | $0 | 45,000 | Dec 22, 2025 |
| Dec 22, 2025 | Danielle Watson See Remarks | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Dec 22, 2025 |
| Dec 22, 2025 | Brian Szymczak director | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Dec 22, 2025 |
| Nov 28, 2025 | Andrew Simpson See Remarks | AGrant or award Common Stock, $0.001 par value | +70,000 | - | - | 74,382 | Nov 28, 2025 |
| Jul 29, 2025 | Mark T Hilz COO, Secretary and Director | SOpen-market sale Common Stock, $0.001 par value10b5-1 | -4,416 | $3.54 | $16k | 4,752 | Jul 30, 2025 |
| Jul 9, 2025 | Bruce Bent director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jul 14, 2025 |
| Jul 9, 2025 | Mark T Hilz See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | - | - | 225,000 | Jul 11, 2025 |
| Jul 9, 2025 | Danielle Watson See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jul 11, 2025 |
| Jul 9, 2025 | David R. Wells director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jul 11, 2025 |
| Jul 9, 2025 | Andrew Simpson See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | - | - | 275,000 | Jul 11, 2025 |
| Jul 9, 2025 | Brian Szymczak director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jul 11, 2025 |
| Jul 9, 2025 | Mark T Hilz See Remarks | AGrant or award Restricted Stock Unitsderivative | +56,250 | $0.00 | $0 | 56,250 | Jul 11, 2025 |
| Jul 9, 2025 | Andrew Simpson See Remarks | AGrant or award Restricted Stock Unitsderivative | +68,750 | $0.00 | $0 | 68,750 | Jul 11, 2025 |
| Jan 16, 2025 | Bruce Bent director | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,000 | - | - | 6,000 | Jan 23, 2025 |
| Jan 16, 2025 | Mark T Hilz See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +45,000 | - | - | 45,000 | Jan 21, 2025 |
| Jan 16, 2025 | Andrew Simpson See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +45,000 | - | - | 45,000 | Jan 21, 2025 |
| Jan 16, 2025 | Brian Szymczak director | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,000 | - | - | 6,000 | Jan 21, 2025 |
| Jan 16, 2025 | Danielle Watson See Remarks | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,000 | - | - | 9,000 | Jan 21, 2025 |
| Jan 16, 2025 | David R. Wells director | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,000 | - | - | 6,000 | Jan 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Bruce Bentdirector
- Mark T HilzSee Remarks
- Andrew SimpsonSee Remarks
- Brian Szymczakdirector
- Danielle WatsonSee Remarks
- David R. Wellsdirector, cfo, officer
Questions about HSCS
Answered from the filings on this page, as of the latest one.
Are insiders buying HSCS?
No. In the last 90 days no insider at HeartSciences Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade HSCS on the open market?
Mark T Hilz (COO, Secretary and Director) sold $16k of HSCS on Jul 29, 2025 and filed the Form 4 on Jul 30, 2025. InsiderTell scored 10 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at HeartSciences Inc.?
6 people have filed a Form 4 at HeartSciences Inc., among them Bruce Bent (director), Mark T Hilz (See Remarks), Andrew Simpson (See Remarks). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.